The global orthopedic devices market size is calculated at USD 65.79 billion in 2025 and is forecasted to reach around USD 96.43 billion by 2034, accelerating at a CAGR of 4.34% from 2025 to 2034. The North America orthopedic devices market size surpassed USD 29 billion in 2024 and is expanding at a CAGR of 4.45% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sourcesa
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
7.1. Orthopedic Devices Market, by Product Type, 2025-2034
7.1.1. Joint Reconstruction
7.1.1.1. Knee Replacement
7.1.1.2. Elbow & Shoulder Replacement
7.1.1.3. Hip Replacement
7.1.1.4. Market Revenue and Forecast (2022-2034)
7.1.2. Orthopedic Prosthetics
7.1.2.1. Market Revenue and Forecast (2022-2034)
7.1.3. Spinal Devices
7.1.3.1. Market Revenue and Forecast (2022-2034)
7.1.4. Trauma Fixation
7.1.4.1. Market Revenue and Forecast (2022-2034)
7.1.5. Arthroscopy Devices
7.1.5.1. Market Revenue and Forecast (2022-2034)
7.1.6. Orthopedic Accessories
7.1.6.1. Market Revenue and Forecast (2022-2034)
7.1.7. Orthopedic Braces and Supports
7.1.7.1. Market Revenue and Forecast (2022-2034)
7.1.8. Others
7.1.8.1. Market Revenue and Forecast (2022-2034)
8.1. Orthopedic Devices Market, by Application, 2025-2034
8.1.1. Ambulatory Surgical Centers
8.1.1.1. Market Revenue and Forecast (2022-2034)
8.1.2. Hospitals
8.1.2.1. Market Revenue and Forecast (2022-2034)
8.1.3. Orthopedic Clinics
8.1.3.1. Market Revenue and Forecast (2022-2034)
8.1.4. Others
8.1.4.1. Market Revenue and Forecast (2022-2034)
9.1. North America
9.1.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.3. U.S.
9.1.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.1.4. Rest of North America
9.1.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.1.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2. Europe
9.2.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.3. UK
9.2.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.4. Germany
9.2.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.5. France
9.2.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.2.6. Rest of Europe
9.2.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.2.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.3. APAC
9.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.3. India
9.3.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.4. China
9.3.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.5. Japan
9.3.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.3.6. Rest of APAC
9.3.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.3.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.4. MEA
9.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.3. GCC
9.4.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.4. North Africa
9.4.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.4.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.5. South Africa
9.4.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.4.6. Rest of MEA
9.4.6.1. Market Revenue and Forecast, by Product (2022-2034)
9.4.6.2. Market Revenue and Forecast, by Application (2022-2034)
9.5. Latin America
9.5.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.3. Brazil
9.5.3.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.3.2. Market Revenue and Forecast, by Application (2022-2034)
9.5.4. Rest of LATAM
9.5.4.1. Market Revenue and Forecast, by Product (2022-2034)
9.5.4.2. Market Revenue and Forecast, by Application (2022-2034)
10.1. Medacta
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. DePuySynthes
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Smith & Nephew
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Stryker
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Medtronic
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Zimmer Biomet
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. MicroPort Scientific Corporation (Wright Medical Group)
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. DJO Global
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. ConforMIS
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. NuVasive
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
10.11. Globus Medical
10.11.1. Company Overview
10.11.2. Product Offerings
10.11.3. Financial Performance
10.11.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client